Journal of Biosciences and Medicines
Vol.1 No.3(2013), Paper ID 40690, 4
pages
DOI:10.4236/jbm.2013.13001
Prohibitins, novel vitamin K2 target factors in osteoblast
Tatsuya Uebi, Makoto Umeda, Naoya Maekawa, Satoshi Karasawa, Hiroshi Handa, Takeshi Imai
Department of Aging Intervention, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan
Department of Aging Intervention, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan
Department of Aging Intervention, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan
Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan
Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan
Department of Aging Intervention, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan
Copyright © 2013 Tatsuya Uebi, Makoto Umeda, Naoya Maekawa, Satoshi Karasawa, Hiroshi Handa, Takeshi Imai et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Uebi, T. , Umeda, M. , Maekawa, N. , Karasawa, S. , Handa, H. and Imai, T. (2013) Prohibitins, novel vitamin K2 target factors in osteoblast.
Journal of Biosciences and Medicines,
1, 1-4. doi:
10.4236/jbm.2013.13001.